Soligenix announced exclusive licensing agreement for novel vaccine adjuvant from BTG Specialty Pharmaceuticals
On Apr. 16, 2020, Soligenix announced it has executed an agreement for the exclusive worldwide license of CoVaccine…
-
-
Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 16, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…
-
COVID-19 | Infectious Disease | NIH | Vaccine
IVI, INOVIO, and KNIH partner with CEPI in phase 1/2 clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea
On Apr. 16, 2020, the International Vaccine Institute (IVI) announced that the Coalition for Epidemic Preparedness Innovations (CEPI)…
-
Mammoth Biosciences announced peer-reviewed validation of its rapid, CRISPR-based COVID-19 diagnostic
On Apr. 16, 2020, Mammoth Biosciences announced the publication of a study demonstrating the power of its platform…
-
Fujifilm accelerated production of its influenza antiviral drug ‘Avigan tablet’ for COVID-19
On Apr. 15, 2020, FUJIFILM announced that it had expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
-
Biotechnology | COVID-19 | Diagnostics | Medicine | Therapeutics | Vaccine
The Bill & Melinda Gates Foundation expands its commitment to global COVID-19 response
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
-
Orthoﾒs total antibody test for COVID-19 received Emergency Use Authorization from FDA
On Apr. 15, 2020, the FDA announced it granted Emergency Use Authorization to Ortho Clinical Diagnosticsﾒ total antibody…
-
Todos Medical received medical importer status with U.S. FDA
On Apr. 15, 2020, Todos Medical announced the U.S. Food and Drug Administration (FDA) has accepted Todos Medical’s application…
-
Vanda Pharma and Northwell Health conduct ODYSSEY trial in patients with severe COVID-19 pneumonia
On Apr. 15, 2020, Vanda Pharma and Northwell Health’s research arm, The Feinstein Institutes for Medical Research, announced…
-
Singapore researchers use NanoString’s nCounter to rapidly profile response of immune system to SARS-CoV-2 virus
On Apr. 15, 2020, NanoString Technologies announced the first publication utilizing the nCounter platform and its leading gene…
-
Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
-
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Medicine | Therapeutics
Iceland provides picture of early spread of COVID-19 in population with cohesive public health response
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
-
The Jackson Laboratory to provide expanded Coronavirus testing for Maine hospitals
On Apr. 14, 2020, the Jackson Laboratory (JAX) in collaboration with several Maine regional hospitals, announced additional coronavirus…
-
Mayo Clinic Laboratories launched serology testing in support of COVID-19 response
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
-
BD announced second FDA Emergency Use Authorization, CE Mark for new COVID-19 molecular diagnostic for global use
On Apr. 13, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
-
Alberta Hope COVID-19 study tested early treatment option
On Apr. 13, 2020, COVID-19 study was announced that will recruit 1,600 Albertans to determine whether a prescribed…
-
RedHill Biopharma reported the first two patients treated with opaganib at a leading hospital in Israel
On Apr. 13, 2020, RedHill Biopharma provided an initial update on the compassionate use program with its investigational…
-
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
-
Potential treatment for COVID-19 identified by BenevolentAI using artificial intelligence enters randomised clinical trial
On Apr. 10, 2020, BenevolentAI announced that baricitinib, which it had identified as a potential treatment for COVID-19,…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Medicine | Pharmaceutical | Therapeutics
Data on 53 patients treated with investigational antiviral remdesivir through Compassionate Use Program published in NEJM
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…
-
Terumo BCT and Marker Therapeutics received FDA Emergency Use Authorization to treat acute respiratory failure in COVID-19 patients
On Apr. 10, 2020, Terumo BCT and Marker Therapeutics announced the FDA issued an Emergency Use Authorization (EUA)…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | Medicine | Pharmaceutical | Therapeutics
Fujifilm announced the start of a phase II clinical trial of its influenza antiviral drug ‘Avigan’ Tablet for COVID-19 patients in the U.S.
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
-
Positive data generated by Biosig subsidiary ViralClear on Covid-19 Coronavirus published in bioRxiv
On Apr. 9, 2020, BioSig Technologies announced that an article titled “The IMPDH inhibitor merimepodib suppresses SARS-COV-2 replications”…
-
Washington University launched Clinical trial to evaluate COVID-19 treatment
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
-
LabCorp and Ciox Health announced an agreement to create a comprehensive COVID-19 patient data registry
On Apr. 9, 2020, LabCorp and Ciox Health announced an agreement to collaborate on a comprehensive U.S.-based COVID-19…
-
iBio announced signing of agreements with Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
-
Severely Ill COVID-19 patient at Southern California medical center extubated three days after treatment with CytoDyn’s leronlimab
On Apr. 9, 2020, CytoDyn announced a patient with severe COVID-19 under the care of a leading medical…
-
NIH began clinical trial of hydroxychloroquine as potential therapy for COVID-19
On Apr. 9, 2020, the first participants were enrolled in the trial at Vanderbilt University Medical Center, Nashville,…
-
Arizona COVID-19 Genomics Union to track the virus
On Apr. 8, 2020, TGen, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern…
